Quantification of IGF-1 Receptor May Be Useful in Diagnosing Polycythemia Vera-Suggestion to Be Added to Be One of the Minor Criterion.
Endogenous erythroid colony (EEC) formation is one of the minor criteria for diagnosing polycythemia vera (PV) according to 2008 WHO diagnostic criteria. But EEC requires bone marrow aspiration and sophisticated laboratory procedures; therefore, practically it is rarely used to diagnose PV. Insulin-like growth factor 1 receptor (IGF-1R) was found to be constitutively phosphorylated and was responsible for the EEC formation in PV; therefore, we measured IGF-1R levels in the peripheral blood of 26 PV patients and compared them with those of 33 patients with secondary polycythemia and 29 normal controls. Among the PV patients, 16 were treated with only phlebotomy, 9 received hydroxyurea, and 1 was treated with ruxolinitinib. We found that PV patients treated with only phlebotomy had significantly higher IGF-1R levels than did those PV patients treated with hydroxyurea or ruxolinitinib. None of the secondary PV patients or normal controls had elevated IGR-1R levels, while 14 of 16 (87%) PV patients had significantly elevated IGF-1R levels. The new 2016 WHO has eliminated EEC as a minor criterion for diagnosing PV, but there are still some cases that cannot be definitively diagnosed by the current criteria. Therefore, we suggest that quantifying the IGF-1R level in peripheral blood by flow cytometry to replace EEC as the minor criterion for diagnosing PV.
Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, NY, United States of America.
Jen C
JC
Wang
Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, NY, United States of America.
Guanfang
G
Shi
Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, NY, United States of America.
Stacey
S
Baptiste
Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, NY, United States of America.
Maryna
M
Yarotska
Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, NY, United States of America.
Hemant
H
Sindhu
Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, NY, United States of America.
Ching
C
Wong
Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, NY, United States of America.
Madhumati
M
Kalavar
Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, NY, United States of America.
Vladimir
V
Gotlieb
Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, NY, United States of America.
Andrei
A
Bandarchuk
Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, NY, United States of America.
Hui
H
Chen
D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010766:Phosphorylation; D011087:Polycythemia Vera / Q000097:blood* / Q000175:diagnosis*; D017526:Receptor, IGF Type 1 / Q000097:blood* / Q000378:metabolism
D015415:Biomarkers; D017526:Receptor, IGF Type 1